+852-3069 6950
css@gugent.com.hk
 

Lab filtration products

Your proven partner for laboratory filtration, separation and purification.


Catalog No. Product Net Price
CYT39000046 Sterile ReadyToProcess Hollow Fiber Cartridge, 0.2 3949.5 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT39000047 Sterile ReadyToProcess Hollow Fiber Cartridge 0.45 3949.5 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT39000048 Sterile ReadyToProcess Hollow Fiber Cartridge, 0.65 3949.5 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT28984081 RTPCFP-1-E-35S 5337 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT28984082 RTPCFP-2-E-35S 5337 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT39000056 Sterile ReadyToProcess Hollow Fiber Cartridge 0.1 5521.5 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT39000058 Sterile ReadyToProcess Hollow Fiber Cartridge, 0.45 5521.5 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT39000057 Sterile ReadyToProcess Hollow Fiber Cartridge, 0.2 5544 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT39000059 Sterile ReadyToProcess Hollow Fiber Cartridge, 0.65 5544 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01
CYT39000088 Sterile ReadyToProcess Hollow Fiber Cartridge 0.65 5827.5 
Add to Cart
  • Autoclavable
  • No
  • Application
  • Aseptic clarification and purification of vaccines,monoclonal antibodies, recombinant proteins, and plasmids.\nAseptic cell processing.\nEnvironments where terminal sterilization is not feasible.\nPreclinical through Phase II clinical trials.\nFast-track drug development processes.
  • Pore Size
  • 0.1 µm
  • Material Compliance
  • Biological Reactivity Test, In Vivo per USP 88 Class VI\nL929 MEM Elution Test – ISO 10993-5 (Cytotoxicity)\nHemolysis – Rabbit Blood (direct contact) – ISO 10993-4\nManufactured with materials that comply with EMEA/410/01

Overview

Capsule filters


Cellulose filter papers

Cellulose filter papers used for general filtration and exhibiting particle retention levels down to 2.5 µm.


Centrifugal devices


Filter Plates

Cytiva filter plates offer a selection of membranes, sample well volumes, and tip configurations allowing researchers to select the right plate for their high throughput application while complying with ANSI/SLAS standards for use in robotic systems.


Glass and quartz microfiber filter

Glass and quartz microfiber filter papers for your filtration workflow.


Immunodiagnostics

Pads and membranes for lateral flow, flow through, blotting, and dipstick assays.


Syringeless filters


Syringe filters - non-sterile


Syringe filters - sterile


Tangential flow filtration for labscale


Thimbles

Cellulose, glass, and quartz thimbles for your filtration workflow.





Resources